|
|
| | Orexin 2 Receptor Agonist Basic information |
| Product Name: | Orexin 2 Receptor Agonist | | Synonyms: | Orexin 2 Receptor Agonist;MDK-5220;Orexin 2 Receptor;OREXIN-2 RECEPTOR AGONIST;OREXIN2 RECEPTOR AGONIST;OX2R AGONIST;CS-2719;OREXIN-2 RECEPTOR AGONIST;OREXIN2 RECEPTOR AGONIST;OX2R AGONIST;MDK-5220;MDK-5220;OX2R agonist;MDK-5220(Orexin-2 receptor agonist) | | CAS: | 1796565-52-0 | | MF: | C32H34N4O5S | | MW: | 586.7 | | EINECS: | | | Product Categories: | | | Mol File: | 1796565-52-0.mol |  |
| | Orexin 2 Receptor Agonist Chemical Properties |
| density | 1.275±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml; DMSO: 20 mg/ml | | form | A crystalline solid | | pka | 7.85±0.10(Predicted) |
| | Orexin 2 Receptor Agonist Usage And Synthesis |
| Uses | 4''-Methoxy-N,N-dimethyl-3''-[[[3-[[2-[(3-methylbenzoyl)amino]ethyl]amino]phenyl]amino]sulfonyl]-[1,1''-biphenyl]-3-carboxamide is an intermediate used to prepare sulfonamide derivatives as orexin receptor agonist for treatment of narcolepsy. |
| | Orexin 2 Receptor Agonist Preparation Products And Raw materials |
|